Navidea Biopharmaceuticals Inc (NAVB)

[KnightlyCruiser]

This is a startup bio tech. All startups go through this BS, no earnings and a buttload of debt. I am positive that LS will be the standard of care in the pharma industry. Poor decision on GE or Crede? Maybe we will take that up next year when we are running at full speed [hopefully]. Currently the company has to do what it has to in order to stay afloat. Not feeling it with the estimate of a $1.50 drop. Maybe a flash crash but not on volume and decreasing SP. Why would management make secret phone calls to shorts? That is way out there. I feel the company is under valued looking forward, under valued now with the current dilution and when I consider all of the pieces as one I feel that we are playing around the bottom currently as we await a catalyst- an earning surprise of $500K or more will have it going back up.Under $300K would be a disappointment. EU partner will happen and I hope it happens at favorable terms for the company. I do not like the slide- the old saying back up the truck and load up is apt at the moment.